FDA
-
-
-
-
-
-
-
Jounce Therapeutics Achieves First Milestone in Exclusive License Agreement with Gilead Sciences and FDA Clearance of Investigational New Drug Application for Anti-CCR8 Antibody
-
-
-
-
-
-
-
Loncar Cancer Immunotherapy Index Conducts Semi-Annual Rebalance
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

